News of Note—Sanofi, ImmusanT and more

newspaper
(Pixabay)

Here is some other vaccine news of note for the week:

> Dyadic will collaborate with Sanofi to explore how its C1 gene expression platform can be applied to Sanofi's vaccine and biologic offerings. The platform aims to speed development and reduce production costs for biologics. Release

> ImmusanT picked up funding from JDRF to work on a Type 1 diabetes vaccine. FierceBiotech article

INDUSTRY RESEARCH

Veeva 2019 Unified Clinical Operations Survey

Share your thoughts in this quick survey. The first 50 qualified respondents will receive a $5 Amazon gift card, and, in appreciation for your time, all qualified survey respondents will be entered in a drawing to win a $50 Amazon gift card.

> A drug combo containing a cancer vaccine showed promise against melanoma in a preclinical study. Release